Dexmedetomidine	dexmedetomidine	O	O
,	,	O	O
acting	acting	O	O
through	through	O	O
central	central	O	O
alpha-2	alpha-2	O	O
adrenoceptors	adrenoceptors	O	O
,	,	O	O
prevents	prevents	O	O
opiate-induced	opiate-induced	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	S_disease
in	in	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

The	the	O	O
highly-selective	highly-selective	O	O
alpha-2	alpha-2	O	O
adrenergic	adrenergic	B_chemical	O
agonist	agonist	I_chemical	O
dexmedetomidine	dexmedetomidine	O	O
(	(	O	O
D-MED	d-med	O	O
)	)	O	O
is	is	O	O
capable	capable	O	O
of	of	O	O
inducing	inducing	O	O
muscle	muscle	O	O
flaccidity	flaccidity	O	O
and	and	O	O
anesthesia	anesthesia	O	O
in	in	O	O
rats	rats	O	O
and	and	O	O
dogs	dogs	O	O
.	.	O	O

Intense	intense	O	O
generalized	generalized	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	S_disease
is	is	O	O
an	an	O	O
undesirable	undesirable	O	O
side	side	O	O
effect	effect	O	O
of	of	O	O
potent	potent	O	O
opiate	opiate	O	O
agonists	agonists	O	O
.	.	O	O

Although	although	O	O
the	the	O	O
neurochemistry	neurochemistry	O	O
of	of	O	O
opiate-induced	opiate-induced	O	O
rigidity	rigidity	O	S_disease
has	has	O	O
yet	yet	O	O
to	to	O	O
be	be	O	O
fully	fully	O	O
elucidated	elucidated	O	O
,	,	O	O
recent	recent	O	O
work	work	O	O
suggests	suggests	O	O
a	a	O	O
role	role	O	O
for	for	O	O
a	a	O	O
central	central	O	O
adrenergic	adrenergic	O	O
mechanism	mechanism	O	O
.	.	O	O

In	in	O	O
the	the	O	O
present	present	O	O
study	study	O	O
,	,	O	O
the	the	O	O
authors	authors	O	O
determined	determined	O	O
if	if	O	O
treatment	treatment	O	O
with	with	O	O
D-MED	d-med	O	O
prevents	prevents	O	O
the	the	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	S_disease
caused	caused	O	O
by	by	O	O
high-dose	high-dose	O	O
alfentanil	alfentanil	S_chemical	O
anesthesia	anesthesia	O	O
in	in	O	O
the	the	O	O
rat	rat	O	O
.	.	O	O

Animals	animals	O	O
(	(	O	O
n	n	O	O
=	=	O	O
42	42	O	O
)	)	O	O
were	were	O	O
treated	treated	O	O
intraperitoneally	intraperitoneally	O	O
with	with	O	O
one	one	O	O
of	of	O	O
the	the	O	O
following	following	O	O
six	six	O	O
regimens	regimens	O	O
:	:	O	O
1	1	O	O
)	)	O	O
L-MED	l-med	O	O
(	(	O	O
the	the	O	O
inactive	inactive	O	O
L-isomer	l-isomer	O	O
of	of	O	O
medetomidine	medetomidine	O	O
)	)	O	O
,	,	O	O
30	30	O	O
micrograms/kg	micrograms/kg	O	O
;	;	O	O
2	2	O	O
)	)	O	O
D-MED	d-med	O	O
,	,	O	O
10	10	O	O
micrograms/kg	micrograms/kg	O	O
;	;	O	O
3	3	O	O
)	)	O	O
D-MED	d-med	O	O
,	,	O	O
30	30	O	O
micrograms/kg	micrograms/kg	O	O
;	;	O	O
4	4	O	O
)	)	O	O
D-MED	d-med	O	O
[	[	O	O
30	30	O	O
micrograms/kg	micrograms/kg	O	O
]	]	O	O
and	and	O	O
the	the	O	O
central-acting	central-acting	O	O
alpha-2	alpha-2	O	O
antagonist	antagonist	O	O
,	,	O	O
idazoxan	idazoxan	O	O
[	[	O	O
10	10	O	O
mg/kg	mg/kg	O	O
]	]	O	O
;	;	O	O
5	5	O	O
)	)	O	O
D-MED	d-med	O	O
[	[	O	O
30	30	O	O
micrograms/kg	micrograms/kg	O	O
]	]	O	O
and	and	O	O
the	the	O	O
peripheral-acting	peripheral-acting	O	O
alpha-2	alpha-2	O	O
antagonist	antagonist	O	O
DG-5128	dg-5128	O	O
[	[	O	O
10	10	O	O
mg/kg	mg/kg	O	O
]	]	O	O
,	,	O	O
or	or	O	O
;	;	O	O
6	6	O	O
)	)	O	O
saline	saline	O	O
.	.	O	O

Baseline	baseline	O	O
electromyographic	electromyographic	O	O
activity	activity	O	O
was	was	O	O
recorded	recorded	O	O
from	from	O	O
the	the	O	O
gastrocnemius	gastrocnemius	O	O
muscle	muscle	O	O
before	before	O	O
and	and	O	O
after	after	O	O
drug	drug	O	O
treatment	treatment	O	O
.	.	O	O

Each	each	O	O
rat	rat	O	O
was	was	O	O
then	then	O	O
injected	injected	O	O
with	with	O	O
alfentanil	alfentanil	S_chemical	O
(	(	O	O
ALF	alf	O	S_disease
,	,	O	O
0.5	0.5	O	O
mg/kg	mg/kg	O	O
sc	sc	O	O
)	)	O	O
.	.	O	O

ALF	alf	O	S_disease
injection	injection	O	O
resulted	resulted	O	O
in	in	O	O
a	a	O	O
marked	marked	O	O
increase	increase	O	O
in	in	O	O
hindlimb	hindlimb	O	O
EMG	emg	O	O
activity	activity	O	O
in	in	O	O
the	the	O	O
L-MED	l-med	O	O
treatment	treatment	O	O
group	group	O	O
which	which	O	O
was	was	O	O
indistinguishable	indistinguishable	O	O
from	from	O	O
that	that	O	O
seen	seen	O	O
in	in	O	O
animals	animals	O	O
treated	treated	O	O
with	with	O	O
saline	saline	O	O
.	.	O	O

In	in	O	O
contrast	contrast	O	O
,	,	O	O
D-MED	d-med	O	O
prevented	prevented	O	O
alfentanil-induced	alfentanil-induced	O	O
muscle	muscle	O	B_disease
rigidity	rigidity	O	S_disease
in	in	O	O
a	a	O	O
dose-dependent	dose-dependent	O	O
fashion	fashion	O	O
.	.	O	O

The	the	O	O
small	small	O	O
EMG	emg	O	O
values	values	O	O
obtained	obtained	O	O
in	in	O	O
the	the	O	O
high-dose	high-dose	O	O
D-MED	d-med	O	O
group	group	O	O
were	were	O	O
comparable	comparable	O	O
with	with	O	O
those	those	O	O
recorded	recorded	O	O
in	in	O	O
earlier	earlier	O	O
studies	studies	O	O
from	from	O	O
control	control	O	O
animals	animals	O	O
not	not	O	O
given	given	O	O
any	any	O	O
opiate	opiate	O	O
.	.	O	O

The	the	O	O
high-dose	high-dose	O	O
D-MED	d-med	O	O
animals	animals	O	O
were	were	O	O
flaccid	flaccid	O	O
,	,	O	O
akinetic	akinetic	O	S_disease
,	,	O	O
and	and	O	O
lacked	lacked	O	O
a	a	O	O
startle	startle	O	O
response	response	O	O
during	during	O	O
the	the	O	O
entire	entire	O	O
experimental	experimental	O	O
period.(ABSTRACT	period.(abstract	O	O
TRUNCATED	truncated	O	O
AT	at	O	O
250	250	O	O
WORDS	words	O	O
)	)	O	O

